Celltrion Healthcare
Scope
Date
~
-
Pharmaceuticals
Celltrion, Humasis to ship $300 mn COVID-19 test kits to US
South Korea's biopharmaceutical company Celltrion Inc. and diagnostic kit manufacturer Humasis Co. have signed contracts to supply their jointly-dev...
Feb 04, 2022 (Gmt+09:00)
-
Korean stock market
EcoPro BM beats Kosdaq's top market cap Celltrion
EcoPro BM Co., a leading manufacturer of cathode material for secondary batteries, topped the market capitalization for Kosdaq-listed firms on Jan...
Jan 19, 2022 (Gmt+09:00)
language -
Korean startups
SK Networks invests in AI-based US healthcare startup LVIS
South Korea’s SK Networks Co. said on Tuesday it joined a $15 million in Series B-2 funding for US healthcare startup LVIS Corp.LVIS, headquar...
Jan 11, 2022 (Gmt+09:00)
-
Sovereign wealth funds
KIC eyes tech, healthcare, telecoms via PE and VC
Korea Investment Corporation (KIC) aims to increase alternative investment to 25% of its total investment by 2025 as well as rank among the world's ...
Jan 05, 2022 (Gmt+09:00)
-
Pharamaceuticals, biotech
Celltrion to conduct tests on Omicron variant detected in Korea
Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...
Dec 06, 2021 (Gmt+09:00)
-
Tech, Media & Telecom
Kakao extends rivalry with Naver into digital healthcare
Kakao Corp., an operator of South Korea's top mobile messenger app KakaoTalk, has set its sights on the digital healthcare market, launching an in-h...
Dec 03, 2021 (Gmt+09:00)
-
COVID-19
Celltrion to export COVID-19 treatment to Europe in 2021
South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...
Nov 30, 2021 (Gmt+09:00)
language -
Biotech
Celltrion looks beyond biosimilars to develop its own mRNA drugs
South Korea’s Celltrion Inc. has long been a biosimilar player, producing replicas of original drugs, a growing market in the pandemic era.Ear...
Nov 16, 2021 (Gmt+09:00)
-
COVID-19
Celltrion wins COVID-19 treatment approval from Europe
South Korea’s pharmaceutical giant Celltrion Inc. has won final approval for its COVID-19 treatment Regkirona from the European Commission, a ...
Nov 15, 2021 (Gmt+09:00)
language -
ASK 2021
KIC to raise alternative investments to 25% by 2027
Korea Investment Corp. (KIC) plans to increase alternative investments to a quarter of its portfolio by 2027 from the current 16%, its CEO Jin Seoun...
Oct 27, 2021 (Gmt+09:00)
-
Healthcare
InBody to expand into household, blood pressure monitoring markets
South Korea’s InBody Co., the global market leader of body composition analyzer devices, will be making a strategic turn to focus on the fast-...
Oct 06, 2021 (Gmt+09:00)
-
Corporate governance
Celltrion makes first step in streamlining governance structure
South Korea’s pharmaceutical conglomerate Celltrion Group has made its very first step in reforming corporate governance structure by merging ...
Sep 17, 2021 (Gmt+09:00)
language -
Pharmaceuticals
High-priced drugs add to pressure for Korea's healthcare reform
A number of new rare disease treatments, approved in South Korea over the past year, are still unaffordable for the public because of their price ta...
Sep 15, 2021 (Gmt+09:00)
-
M&As
Lotte teams up with IMM PE to acquire furniture maker Hanssem
Lotte Group is seeking to acquire a stake in Hanssem Co., South Korea’s largest furniture and home furnishing company, with an investment of u...
Sep 01, 2021 (Gmt+09:00)
language -
Digital healthcare
Naver to enter healthcare business in Korea with investment in ezCaretech
South Korea’s online platform giant Naver Corp. is set to enter the big data-based healthcare industry by investing in ezCaretech Co., a domes...
Aug 25, 2021 (Gmt+09:00)
-
Covid-19 treatment
Brazil gives emergency use nod for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...
Aug 13, 2021 (Gmt+09:00)
language -
COVID-19
Celltrion to enter clinical trials of new COVID-19 treatment
South Korean biosimilar maker Celltrion Inc. will launch the first-phase clinical trials of its new COVID-19 treatment candidate next month, followi...
Aug 05, 2021 (Gmt+09:00)
language -
Future Mobility
Hyundai Mobis targets in-vehicle healthcare with brainwave technology
South Korea’s top auto parts maker Hyundai Mobis has developed a new brainwave detection technology that monitors a driver's physical and psyc...
Jul 21, 2021 (Gmt+09:00)
language -
Covid-19 treatment
Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment
South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...
Jul 20, 2021 (Gmt+09:00)
-
COVID-19
Celltrion’s COVID-19 treatment reduces incidence of severity by 70%
Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...
Jul 13, 2021 (Gmt+09:00)
language -
Biosimilars
Celltrion, Samsung Bioepis anticipate increased biosimilar sales in Europe
South Korean biosimilar companies such as Celltrion Inc. and Samsung Bioepis Co. are likely to see their sales hike by tens of millions of dollars...
Jul 12, 2021 (Gmt+09:00)
-
Pharmaceuticals
SK Biopharm aims to make it to global top 10 healthcare firms by 2030
South Korea’s SK Biopharmaceuticals Co. said on Friday it aspires to become one of the world’s top 10 healthcare companies by 2030 with ...
Jul 02, 2021 (Gmt+09:00)
-
Korean startups
Impressivo to bridge fitness and healthcare industry via sensing technology
San Francisco-based startup Impressivo is seeking partnerships in the fitness and healthcare sector as the company aims to bridge the fitness and he...
Jun 30, 2021 (Gmt+09:00)
-
Biotech
Seegene develops one-stop COVID-19 testing lab on wheels; eyes MENA expansion
South Korea-based diagnostic kit maker Seegene Inc. has developed a mobile diagnostic and testing lab that offers a one-stop solution for COVID-19 t...
Jun 25, 2021 (Gmt+09:00)
-
Healthcare
Israel’s Nanox begins production of digital X-ray components in Korea
Nano-X Imaging Ltd. (Nanox), an Israeli startup listed on the Nasdaq last August, has started manufacturing digital X-ray components in South Korea....
Jun 22, 2021 (Gmt+09:00)
-
Robotics
Samsung Electronics to market wearable robot for healthcare by year-end
Samsung Electronics Co. will commercialize a wearable robot for healthcare by the end of this year as the South Korean tech giant is delving into th...
Jun 15, 2021 (Gmt+09:00)
language -
Medicine
Celltrion, Mirae to take largest stake in UK biotech firm
South Korean biosimilar maker Celltrion Inc. and Mirae Asset Group have agreed to an investment that will render them the top shareholder in Iksuda ...
Jun 07, 2021 (Gmt+09:00)
language -
Artificial intelligence
Samsung, Bayer join $90 mn investment in AI healthcare app Ada Health
Samsung Electronics Co. and Germany’s pharmaceutical giant Bayer AG have made a joint investment in the Berlin-based artificial intelligence (...
May 28, 2021 (Gmt+09:00)
-
Celltrion eyes COVID-19 vaccine development
South Korea-based Celltrion Inc. has alluded to the possibility of developing a COVID-19 vaccine on the grounds that securing a vaccine is essential...
Feb 19, 2021 (Gmt+09:00)
language -
Short selling
Retail investors test Celltrion, HLB shares as Korea’s GameStop
Celltrion Inc. and HLB Inc., two leading South Korean biopharmaceutical shares, shot up on Monday as the main bourse’s key index climbed back ...
Feb 01, 2021 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google